Anti-rabies antibody: Preliminary Phase II data

Preliminary results from a single-blind, U.S. Phase II trial in 140 healthy volunteers showed that injection site reactions occurred in those receiving CL184 (n=80), sanofi's marketed Imogram Rabies H...